T7665

[Leu5]-Enkephalin TFA(58822-25-6(free bas)) (Leucyl-enkephalin) is the most potent δ-receptor ago

PAR-2 (1-6) (human) (SLIGKV), a peptide ligand and PAR-2 agonist, [1].

Peptide YY (13-36) (canine, mouse, porcine, rat) is a Y2 receptor subtype agonist [1].

PHF6 (VQIVYK), a sequence within the third microtubule-binding repeat region of the tau protein, initiates the aggregation of the full-length tau protein through its self-assembly capabilities [1].

Polybia-MP1 is an antimicrobial mastoparan peptide.

Polyphemusin II-Derived Peptide (T140), a CXCR4 inhibitor, effectively blocks HIV-1 entry and hinders the binding of the anti-CXCR4 monoclonal antibody (12G5) to CXCR4 [1].

Human Prokineticin-2 peptide (28-74, 96-128) is a truncated version of human Prokineticin-2 (PROK2), derived from SEQ NO:6 in Patent WO2002036625A2, and can be used for relevant research in the life sciences field. Prokineticin-2 (human) is a regulatory hypothalamic neuropeptide that plays a role in food intake, thermoregulation, and energy metabolism.

Pseudin-2, an antimicrobial peptide (AMP) isolated from the skin of the South American paradoxical frog (Pseudis paradoxa), demonstrates a potent inhibitory effect on the growth of Gram-negative bacteria [1].

Human PTH-(1-31), the 1-31 fragment of human parathyroid hormone, stimulates cAMP release and mildly activates 25-hydroxyvitamin D-1α-hydroxylase. Unlike its full-length counterpart, it promotes bone formation without triggering bone resorption, making it a promising candidate for osteoporosis research [1] [2].

Human PTH-(1-31) amide, an analog of PTH, effectively stimulates phosphatidylcholine hydrolysis and promotes the release of adenylyl cyclase [1].

SYNV-cyclo(CGGYF), a C5 autoinducing peptide from Staphylococcus hominis (S. hominis), demonstrates inhibitory effects on Staphylococcus aureus (S. aureus) activity. This compound shows promise in research focused on addressing S. aureus-mediated epithelial damage and inflammation [1].

SYNV-cyclo(CGGYF) TFA, a C5 autoinducing peptide derived from Staphylococcus hominis (S. hominis), demonstrates inhibition of S. aureus activity, holding potential for research into S. aureus-mediated epithelial damage and inflammation [1].